Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia

Publisher: John Wiley & Sons Inc

E-ISSN: 1097-0142|119|21|3805-3811

ISSN: 0008-543x

Source: CANCER, Vol.119, Iss.21, 2013-11, pp. : 3805-3811

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content